Stay updated on Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.

Latest updates to the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page
- Check4 days agoChange DetectedAdded a MedlinePlus Genetics topic on Melanoma and updated the page to revision v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.4%
- Check11 days agoChange DetectedThe page has been updated to version 3.0.1, and the previous version 3.0.0 has been removed. Additionally, the section on Melanoma related topics from MedlinePlus Genetics has been deleted.SummaryDifference0.4%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on various medical proteins and antibodies. Notably, the revision number has been updated to v3.0.0.SummaryDifference3%
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.